Abstract
BackgroundBCMA-targeted chimeric antigen receptor (CAR)T-cell therapy promotes transient recovery in patients with multiple myeloma, but relapses occurs commonly. GPRC5D, a surface receptor that is highly expressed in bone marrow samples...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have